Research and Evaluation

Much of the near doubling of global life expectancy achieved over the past century can be attributed to advances resulting from medical research. The development of an innovative treatment for tuberculosis, for example, has significantly helped control this disease in many parts of the world. With its commitment to improving real-world health outcomes, Vital Strategies works to push research evidence of all kinds into action.

Medical research is not the only tool to improve public health, however. Economic research has also been critical in changing public policy. For example, economic analyses of how tobacco prices affect consumption have influenced tax and pricing policies that have helped millions to quit smoking.

Evidence underpins every Vital Strategies program. We work to further the evidence by turning scientific research into practical applications and policies.

For example, since 2012 The Union North America has worked with other Union offices and global partners to implement the STREAM clinical trial, which is evaluating shortened treatment regimens for multidrug-resistant tuberculosis in several countries worldwide. 

Vital Strategies will continue this important work with these partners. This landmark trial will provide evidence on the effectiveness of regimens as short as six (6) months’ duration compared to the current treatment duration of 24 months – a potentially enormous step forward for both affected communities and the health systems that serve them.


Policy Advocacy

We use media advocacy and data resources like The Tobacco Atlas -  the most quoted source for global tobacco control data and policy – to drive adoption of best practice and policies.

Project Management

Initiatives managed by our legacy organizations have distributed more than $US 100 million to governments and civil society groups in more than 96 countries.

Strategic Communication

More than 2 billion people have been reached by one of our campaigns, using paid media like TV, social and mobile media, and community-level mobilization.

Workplace Development

Since 2010 our staff have trained more than 5100 people from 136 countries in critical public health areas.

Research

STREAM TB clinical trial in several countries has potential to reduce treatment duration from 24 to 6 months. Vital Strategies will continue this promising work with Union offices and partners around the world.

Epidemiology and Surveillance

Our Data For Health Program is working to improve data collection and analysis in twenty countries